
Researchers at the University of Southampton are inviting parents and caregivers of young infants to take part in a research study to help prevent food allergy in babies. This research is part of a doctorate project led by Karen Wright,
Read more
A new study using data from the European Anaphylaxis Registry has identified important changes in which tree nuts are most likely to cause serious allergic reactions (anaphylaxis) in children and adults across Europe. The results show that cashew nuts are
Read more
A new study, led by King’s College London and Guy’s and St Thomas’ NHS Foundation Trust, has shown promising results, demonstrating that peanut oral immunotherapy (OIT) may be an effective treatment for adults with peanut allergies. The trial, known as
Read more
Researchers at the University of Bristol and the James Lind Alliance invite you to take part in the second phase of a UK-wide survey to prioritise the most urgent unanswered questions about childhood food allergy. This is the second part of the
Read more
Last week Anaphylaxis UK celebrated National Weaning Week 2025—a time dedicated to supporting families as they introduce solid foods to their babies. We marked the occasion by publishing a podcast, offering practical, evidence-based information on safely introducing common allergens during
Read more
We are delighted to announce that Anaphylaxis UK has been successful in its application to Innovate UK for funding to set up a Knowledge Transfer Partnership (KTP) with the University of Surrey to offer support that addresses the psychological impact of living with serious allergies.
Read more
A recent study led by researchers at the Icahn School of Medicine at Mount Sinai, New York, has provided encouraging evidence that a supervised, gradual peanut ingestion protocol may help children with a high-threshold peanut allergy increase their tolerance to
Read more
The University of Manchester is inviting individuals to participate in an event where they can share their healthcare experiences and contribute to meaningful discussions with student researchers. This research opportunity aims to help students learn directly from patients about their
Read more
The National Institute for Health and Care Excellence (NICE) has released its final draft guidance, recommending Acarizax for NHS use in the management of house dust mite allergy. Developed by ALK-Abello, Acarizax is the first therapy specifically designed to treat
Read more